Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Metadata
Title
Effect of Highly Active Antiretroviral Therapy on Hospitalization Characteristics of HIV-Infected Patients
Authors
R. Nuesch
N. Geigy
E. Schaedler
M. Battegay
Publication date
01-09-2002
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2002
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-002-0792-3

Other articles of this Issue 9/2002

European Journal of Clinical Microbiology & Infectious Diseases 9/2002 Go to the issue

Concise Article

Vibrio cholerae Bacteremia in a Neutropenic Patient with Non-Small-Cell Lung Carcinoma

Announcements

September 2002

Editorial

Delayed Occurrence of Cytomegalovirus Disease in Organ Transplant Recipients Receiving Antiviral Prophylaxis: Are We Winning the Battle Only to Lose the War?

Review

Activity of Quinolones Against Gram-Positive Cocci: Mechanisms of Drug Action and Bacterial Resistance

Concise Article

Prospective Assessment of a New Polymerase Chain Reaction Target (STEVOR) for Imported Plasmodium falciparum Malaria

Letter to the Editor

Penicillin Therapy for Anthrax: A Reply to Torres-Tortosa et al.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits